JMP Securities Upgrades Sarepta Therapeutic (SRPT) to Market Outperform
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $18.79 -2.24%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
JMP Securities upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Market Underperform to Market Outperform with a price target of $60.00 (from $10.00).
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $28.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
